There’s a question a lot of research sites are quietly asking right now: what would a sponsor think if they found out we were using AI on their trial data at all?

In this packed episode of Note to File, Oliver joins Brad Hightower and Denali Rose to talk about what’s on the mind of any site leader right now: How do sponsors actually feel about sites using AI, and what does the FDA have to say about it? Does eSource even need to exist? Why is data entry still such an unsolved problem in clinical research? What does the future of paper source look like? Oliver gets into Gleam's novel approach and how it's quietly revolutionizing the hands-on workflows and daily operations at sites, how the team infuses fun in a serious work tool, and more.

I say this a lot when I’m building Gleam: I optimize for joy.